Related Experiment Video

Updated: Oct 15, 2025

A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

341

The immune checkpoints storm in COVID-19: Role as severity markers at emergency department admission

José Avendaño-Ortiz1,2, Roberto Lozano-Rodríguez1,2, Alejandro Martín-Quirós3

  • 1The Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain.

Clinical and Translational Medicine
|October 28, 2021
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.9K
Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
04:05

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

2.4K

Related Experiment Videos

Last Updated: Oct 15, 2025

A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

341
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.9K
Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
04:05

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

2.4K

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

1.1K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.1K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

12.8K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.8K

Articles linked to this work by shared authors, journal, and citation graph.

Heat-killed Mycobacterium tuberculosis-induced trained immunity elicits antitumor activity in PBMCs from colon cancer patients with unresponsiveness to anti-PD-1 in vitro.

Frontiers in immunology·2026

Circulating carbohydrate antigen Ca10H predicts favorable prognosis in colorectal cancer.

Scientific reports·2026

Lipid A modification is associated with colistin susceptibility in Serratia nevei clinical isolates.

Scientific reports·2026

Engineering low-endotoxin lipid A in a double auxotroph Pseudomonas aeruginosa to develop safer whole-cell vaccines.

Frontiers in cellular and infection microbiology·2026

Psychometric Properties of Multiattribute Utility Instruments in Pediatric Solid Organ Transplantation and Related Conditions: A COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) Systematic Review.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

The combination of atezolizumab and BCG in high-risk non-muscle invasive bladder cancer: results of the phase Ib/II BladderGATE clinical trial.

The oncologist·2026

A serum proteomics-based predictive model for steroid-resistant immune checkpoint inhibitor associated myocarditis.

Clinical and translational medicine·2026

Integrative characterization of human hepatocellular carcinoma-derived organoids and their HBV-associated biology.

Clinical and translational medicine·2026

USP25 stabilises GLI1 through K48-linked deubiquitination within a reciprocal regulatory circuit in osteoarthritis models.

Clinical and translational medicine·2026

Lactate metabolism and protein lactylation in programmed cell death: From novel mechanism to therapeutic strategies in human diseases.

Clinical and translational medicine·2026

ACP5-positive macrophages contribute to cerebral oedema and neuroinflammation after traumatic brain injury.

Clinical and translational medicine·2026

Circulating tumour cells for guiding antibody‒drug conjugate therapy: Role of artificial intelligence.

Clinical and translational medicine·2026

Protective effects of icariin in atherosclerotic cardiovascular disease: mechanistic basis, post-ischemic protection and translational limitations.

Pharmaceutical biology·2026

B Lymphocytes in Acute Ischemic Stroke: From Immune Tolerance to Neuroprotection and Autoimmunity.

The European journal of neuroscience·2026

Toward regionally equitable precision medicine: microbiota‑associated mechanisms and emerging personalized strategies in multiple sclerosis.

Journal of translational medicine·2026

Lymph node contraction links sex-biased naive CD8+ T cell decline to compromised antigen recognition during middle age.

Nature aging·2026

The H3K27me3-NR1D1-IFN-γ axis in trained macrophages induced by early respiratory virus infection drives non-T2 asthma in children.

Cellular & molecular immunology·2026

Mitochondria transfer via tunneling nanotubes drives macrophage immunosuppression and metabolic reprogramming in pediatric AML.

Leukemia·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us